4//SEC Filing
McCallum Stewart 4
Accession 0001192482-18-000051
CIK 0001588972other
Filed
Jan 21, 7:00 PM ET
Accepted
Jan 22, 5:07 PM ET
Size
8.3 KB
Accession
0001192482-18-000051
Insider Transaction Report
Form 4
McCallum Stewart
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2018-01-18+6,000→ 33,701 total - Tax Payment
Common Stock
2018-01-18$8.89/sh−1,860$16,535→ 31,841 total - Exercise/Conversion
Restricted Stock Units
2018-01-18−6,000→ 18,000 total→ Common Stock (6,000 underlying)
Footnotes (2)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]On January 18, 2017, the reporting person was granted 24,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
Documents
Issuer
Recro Pharma, Inc.
CIK 0001588972
Entity typeother
Related Parties
1- filerCIK 0001659872
Filing Metadata
- Form type
- 4
- Filed
- Jan 21, 7:00 PM ET
- Accepted
- Jan 22, 5:07 PM ET
- Size
- 8.3 KB